单克隆抗体
分子生物学
T细胞受体
生物
T细胞
卵巢癌
抗体
多克隆抗体
细胞溶解
γδT细胞
癌症研究
免疫学
卵巢癌
细胞毒性T细胞
免疫系统
癌症
生物化学
体外
遗传学
作者
Silvano Ferrini,Ignazia Prigione,Serafina Mammouti,Maria I. Colnaghi,Sylvie Ménard,Alessandro Moretta,Lorenzo Moretta
标识
DOI:10.1002/ijc.2910440210
摘要
Abstract TcR gamma/delta + lymphocytes represent a small subset homogeneously composed of cytolytic T cells displaying unique motility and homing properties. Since the lytic machinery of these cells can be efficiently triggered by monoclonal antibodies (MAbs) directed to the TcR gamma/delta, such MAbs were used for the construction of bispecific MAbs in conjunction with an MAb specific for ovarian carcinoma cells. Hybrid hybridomas were obtained by fusing the Mov19 MAb (IgG 2a )‐producing hybridoma with either GI (IgG 2a ) or A13 (IgG 1 ) hybridomas, secreting MAbs specific for 2 peripheral blood subsets of TcR gamma/delta + lymphocytes. Hybrid hybridomas producing bispecific MAbs were screened according to their ability to induce ovarian carcinoma (IGROVI) target cell lysis by GI + or A13 + T cell clones, respectively. The Gl‐derived GM33.9 bispecific MAb induced selective lysis of Mov19 + ovarian carcinoma target cells only by GI + clones, whereas the A13‐derived AM 18.4 MAb was effective only in combination with A13 + clones. Neither the anti‐TcR gamma/ delta nor the Mov19 parental MAbs (used alone or in combination) induced target‐cell lysis. The hybrid nature (IgG 1 / lgG 2a ) of the AM 18.4 bispecific MAb was indicated by 2‐color immunofluorescence experiments. Thus, both ovarian carcinoma and A13 + effector cells were double stained by AM18.4 bispecific MAb followed by PE‐conjugated anti‐IgG 1 and FITC‐conjugated anti‐IgG 2a second reagents. Polyclonal TcR gamma/delta + cells were obtained by direct stimulation of peripheral blood mononuclear cells with Sepharose bead‐conjugated anti‐TcR gamma/delta MAbs and IL‐2. The lines so obtained contained more than 90% of TcR gamma/delta + cells after 4 weeks of culture, with an increase in TcR gamma/ delta + cell numbers ranging from 200 to 1,000‐fold. These TcR gamma/delta + cell lines efficiently lysed ovarian carcinoma target cells in the presence of bispecific MAb and may therefore represent a suitable source of effector cells for induction of ovarian carcinoma cell lysis.
科研通智能强力驱动
Strongly Powered by AbleSci AI